Indeed, we showed that a specific knockdown of wt-IDH2 led to a potent inhibition of leukemia cell proliferation in vitro and in vivo, indicating that specific abrogation of IDH2 could exert significant therapeutic activity against AML. This evidence concerns the gene IDH2 and leukemia.